BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8054483)

  • 1. Interactions between oncostatin M and the IL-6 signal transducer, gp130.
    Liu J; Modrell B; Aruffo A; Scharnowske S; Shoyab M
    Cytokine; 1994 May; 6(3):272-8. PubMed ID: 8054483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
    Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y
    Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal cytokine binding domain of LIFR is required for CNTF binding and signaling.
    He W; Gong K; Smith DK; Ip NY
    FEBS Lett; 2005 Aug; 579(20):4317-23. PubMed ID: 16051226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP: fused receptor domains act as high affinity cytokine-binding proteins.
    Metz S; Wiesinger M; Vogt M; Lauks H; Schmalzing G; Heinrich PC; Müller-Newen G
    J Biol Chem; 2007 Jan; 282(2):1238-48. PubMed ID: 17085445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome.
    Chen YH; Grigelioniene G; Newton PT; Gullander J; Elfving M; Hammarsjö A; Batkovskyte D; Alsaif HS; Kurdi WIY; Abdulwahab F; Shanmugasundaram V; Devey L; Bacrot S; Brodszki J; Huber C; Hamel B; Gisselsson D; Papadogiannakis N; Jedrycha K; Gürtl-Lackner B; Chagin AS; Nishimura G; Aschenbrenner D; Alkuraya FS; Laurence A; Cormier-Daire V; Uhlig HH
    J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31914175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lnterleukin-6 and Its Receptor; From Cloning to Clinic.
    Kishimoto T
    Int Arch Allergy Immunol; 1992; 99(2-4):172-177. PubMed ID: 34167201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific cytokines of interleukin-6 family interact with S100 proteins.
    Kazakov AS; Sokolov AS; Permyakova ME; Litus EA; Uversky VN; Permyakov EA; Permyakov SE
    Cell Calcium; 2022 Jan; 101():102520. PubMed ID: 34933172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gp130 at the nexus of inflammation, autoimmunity, and cancer.
    Silver JS; Hunter CA
    J Leukoc Biol; 2010 Dec; 88(6):1145-56. PubMed ID: 20610800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M is a regulator of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast-like cells.
    Münz S; Feger M; Föller M
    Sci Rep; 2023 May; 13(1):8420. PubMed ID: 37225713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 Cytokine Family: A Putative Target for Breast Cancer Prevention and Treatment.
    Felcher CM; Bogni ES; Kordon EC
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dissection of human interleukin-31-mediated signal transduction through site-directed mutagenesis.
    Le Saux S; Rousseau F; Barbier F; Ravon E; Grimaud L; Danger Y; Froger J; Chevalier S; Gascan H
    J Biol Chem; 2010 Jan; 285(5):3470-7. PubMed ID: 19920145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition and characterization of an inhibitor for interleukin-31.
    Venereau E; Diveu C; Grimaud L; Ravon E; Froger J; Preisser L; Danger Y; Maillasson M; Garrigue-Antar L; Jacques Y; Chevalier S; Gascan H
    J Biol Chem; 2010 May; 285(20):14955-14963. PubMed ID: 20335179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinspired Design of Artificial Signaling Systems.
    Way JC; Burrill DR; Silver PA
    Biochemistry; 2023 Jan; 62(2):178-186. PubMed ID: 35984429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M, Serpins, and Oxidative Stress in Extracellular Matrix Remodeling and Arteriovenous Fistula Maturation.
    DeMarco N; Rai V; Wilson DR; Agrawal DK
    Cardiol Cardiovasc Med; 2023; 7(2):129-140. PubMed ID: 37484520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines.
    West NR
    Front Immunol; 2019; 10():1093. PubMed ID: 31156640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis.
    Browning L; Patel MR; Horvath EB; Tawara K; Jorcyk CL
    Cancer Manag Res; 2018; 10():6685-6693. PubMed ID: 30584363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathies of Stüve-Wiedemann Syndrome due to mutations in leukemia inhibitory factor receptor (LIFR) gene.
    Oxford AE; Jorcyk CL; Oxford JT
    J Neurol Neuromedicine; 2016; 1(7):37-44. PubMed ID: 28058407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology.
    Mikelonis D; Jorcyk CL; Tawara K; Oxford JT
    Orphanet J Rare Dis; 2014 Mar; 9():34. PubMed ID: 24618404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enigmatic cytokine oncostatin m and roles in disease.
    Richards CD
    ISRN Inflamm; 2013 Dec; 2013():512103. PubMed ID: 24381786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.